 <h1>Axid Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>nizatidine</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about nizatidine. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Axid.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to nizatidine: oral capsules, oral tablets for</i></p><p>Side effects include:</p><p>Headache, dizziness.          </p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to nizatidine: oral capsule, oral solution, oral tablet</i></p><h3>General</h3><p>The most commonly reported side effects included headache, rhinitis, abdominal pain, and diarrhea.<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 16.6%)</p><p><b>Common</b> (1% to 10%): Dizziness, somnolence</p><p><b>Frequency not reported</b>: Seizure<sup>[Ref]</sup></p><p>A pediatric patient given 2.5 mg/kg orally 2 times a day for 23 days experienced an EEG-diagnosed seizure during treatment.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Constipation, diarrhea, dry mouth, dyspepsia, flatulence, gastrointestinal disorder, nausea, nausea and vomiting, tooth disorder, vomiting<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Cough, cough increased, nasal congestion, nasopharyngitis, pharyngitis, rhinitis, sinusitis</p><p><b>Postmarketing reports</b>: Bronchospasm, laryngeal edema<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Accident, asthenia, fever, injury, pain, pyrexia, surgical procedure<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Abnormal dreams, anxiety, insomnia, irritability, nervousness</p><p><b>Postmarketing reports</b>: Decreased libido, reversible mental confusion<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Pruritus, rash, sweating, urticaria</p><p><b>Postmarketing reports</b>: Exfoliative dermatitis<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Back pain, myalgia</p><p><b>Postmarketing reports</b>: Arthralgia<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Infection</p><p><b>Rare</b> (0.01% to 0.1%): Serum sickness, serum sickness-like reactions<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Chest pain</p><p><b>Frequency not reported</b>: Short episodes of asymptomatic ventricular tachycardia</p><p><b>Postmarketing reports</b>: Vasculitis<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Anorexia</p><p><b>Postmarketing reports</b>: Hyperuricemia unrelated to gout or nephrolithiasis<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Amblyopia<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Uncommon</b> (0.1% to 1%): Anemia</p><p><b>Postmarketing reports</b>: Agranulocytosis, eosinophilia, fatal thrombocytopenia, leukopenia, thrombocytopenic purpura<sup>[Ref]</sup></p><p>Fatal thrombocytopenia was reported in a patient who experienced possible drug-related thrombocytopenia previously received this drug and another histamine-2 (H2) receptor antagonist.<sup>[Ref]</sup></p><h3>Hepatic</h3><p>Some patients developed ALT and/or AST elevations exceeding 500 international units/L, with a report of an ALT level exceeding 2000 international units/L.</p><p></p><p>Some patients 2 to 18 years developed mild elevations in serum transaminase levels (1 to 2 times the upper limit of normal).</p><p></p><p>Liver enzyme elevations and liver abnormalities were reversible upon discontinuation of treatment.<sup>[Ref]</sup></p><p><b>Rare</b> (0.01% to 0.1%): Transient, marked transaminase elevations, transient, marked alkaline phosphatase elevations</p><p><b>Frequency not reported</b>: Elevated liver enzyme tests (alkaline phosphatase, ALT, AST), hepatocellular injury, transient, asymptomatic transaminase elevations, transient, asymptomatic alkaline phosphatase elevations</p><p><b>Postmarketing reports</b>: Cholestatic injury, cholestatic injury with jaundice, hepatitis, jaundice, mixed hepatocellular injury, mixed hepatocellular injury with jaundice<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p>Hypersensitivity reactions included bronchospasm, eosinophilia, laryngeal edema, and rash.<sup>[Ref]</sup></p><p><b>Postmarketing reports</b>: Anaphylaxis, hypersensitivity reactions<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Postmarketing reports</b>: Impotence<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Postmarketing reports</b>: Gynecomastia<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. "Product Information. Axid (nizatidine)." Lilly, Eli and Company, Indianapolis, IN. </p><h2>More about Axid (nizatidine)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>2 Reviews</li>
<li>Drug class: H2 antagonists</li>
<li>FDA Alerts (2)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Other Formulations</h3><ul class="more-resources-list more-resources-list-formulations">
<li>Axid AR</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Duodenal Ulcer Prophylaxis</li>
<li>GERD</li>
<li>Duodenal Ulcer</li>
<li>Erosive Esophagitis</li>
<li>Indigestion</li>
<li>Stomach Ulcer</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>